THURSDAY, DECEMBER 1, 2005/2:20 P.M. EASTERN (11:20 A.M. PACIFIC) ***MEDIA ALERT*** WHO:
Dr. William Berger M.D., M.B.A. Dr. Berger is an anaphylaxis and allergy expert.
WHAT:
Verus Pharmaceuticals, Inc., a pediatric-oriented specialty pharmaceutical company, is making Dr. William Berger available to the media in light of this week’s deadly peanut butter kiss in Canada. Dr. Berger is available to discuss the rise of allergies among adults and children, symptoms of severe allergic reactions (anaphylaxis) and the newest medications on the market being used today to treat anaphylaxis such as Twinject(TM) auto-injector. Twinject is the first improved version of an epinephrine injector to be put on the market in over twenty years. Notably, Twinject is first and only available product approved by the U.S. Food and Drug Administration that contains two doses of epinephrine in a single device.
WHY:
More than 40 million people in the United States are at risk for anaphylactic episodes. These include symptoms such as hives, swollen tongue and difficulty breathing. It is a severe and potentially fatal allergic reaction to insect stings or bites, drugs and sometimes even common foods as well as other triggers. The highly publicized event in Canada this week was just one of many less touted anaphylactic reactions that happen every day. Individuals can be prepared by carrying Twinject epinephrine auto-injectors to avoid fatality during severe allergic reactions.
FOR MORE INFORMATION OR TO SCHEDULE AN INTERVIEW WITH DR. WILLIAM BERGER CONTACT:
Kathy Witz-Sweeney or Jennifer Mitchell, (858) 455-5500 x220/ x320, kwitz@mentus.com, jmitchell@mentus.com.
About Verus
Verus Pharmaceuticals is dedicated to improving the lives of children and those who care for them. Verus is building a portfolio of products for the unmet medical needs of children through acquisitions and alliances, with an initial focus on the treatment of asthma, allergies, and related diseases and conditions. Verus is differentiated by its pediatric orientation and its strong financial position and experienced management team, which allows the company to capitalize on an extensive network to build its product portfolio and pursue complementary transactions. The company’s rigorous, disciplined approach to strategic decision-making and core competencies in development and commercialization is expected to provide significant value to its partners. More information about Verus is available on the company’s corporate website at www.veruspharm.com.
Forward-Looking Statements
Verus Pharmaceuticals cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Verus that any of its plans will be achieved. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in Verus’ business including, without limitation, statements about: its ability to identify appropriate acquisition, licensing, or co-development and/or promotion candidates in the future or be able to take advantage of the opportunities it identifies; difficulties or delays in developing, obtaining regulatory approval, manufacturing and commercializing its products; unexpected performance or side effects of its products that could delay or prevent development or commercialization, or that could result in recalls or product liability claims; the scope and validity of patent protection for its products; competition from other pharmaceutical companies; and its ability to obtain additional financing to support its operations. All forward-looking statements are qualified in their entirety by this cautionary statement and Verus undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.
Verus Pharmaceuticals, Inc.
CONTACT: Kathy W. Sweeney, ext. 230, kwitz@mentus.com, or JenniferMitchell, ext. 320, jmitchell@mentus.com, both of Mentus, +1-858-455-5500,for Verus Pharmaceuticals
Web site: http://www.veruspharm.com/
